PMS16 ADALIMUMAB, ETANERCEPT AND INFLIXIMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS-BUDGET IMPACT ANALYSIS ON POLISH NATIONAL HEALTH FUND
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66784-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)66784-8/fulltext
Title :
PMS16 ADALIMUMAB, ETANERCEPT AND INFLIXIMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS-BUDGET IMPACT ANALYSIS ON POLISH NATIONAL HEALTH FUND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66784-8&doi=10.1016/S1098-3015(10)66784-8
First page :
Section Title :
Open access? :
No
Section Order :
619